We also found that reduced miR-34a and miR-200c expression are significantly associated with poor BC patient survival in more malignant types of BC, which are negative for estrogen receptor expression (p < 0.05, as per both log-rank and Cox proportional hazard tests for each miRNA) (Figure 1D,E). The gene discussed is ESR1; the disease is breast cancer.